Literature DB >> 24455772

Comparison of Neisseria gonorrhoeae MICs obtained by Etest and agar dilution for ceftriaxone, cefpodoxime, cefixime and azithromycin.

Severin Gose, Carol J Kong, Yer Lee, Michael C Samuel, Heidi M Bauer, Paula Dixon, Olusegun O Soge, John Lei, Mark Pandori.   

Abstract

We evaluated Neisseria gonorrhoeae Etest minimum inhibitory concentrations (MICs) relative to agar dilution MICs for 664 urethral isolates for ceftriaxone (CRO) and azithromycin (AZM), 351 isolates for cefpodoxime (CPD) and 315 isolates for cefixime (CFM). Etest accurately determined CPD, CFM and AZM MICs, but resulted in higher CRO MICs.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24455772

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN： 0167-7012            Impact factor:   2.363


  8 in total

1.  Variability in Azithromycin Susceptibility Results for Neisseria gonorrhoeae Obtained Using Gradient MIC Strip and Agar Dilution Techniques.

Authors:  Gary N McAuliffe; Marian Smith; Gavin Cooper; Rose F Forster; Sally A Roberts
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

2.  In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.

Authors:  Christoph Hauser; Lea Hirzberger; Magnus Unemo; Hansjakob Furrer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

3.  Gradient diffusion susceptibility testing for Neisseria gonorrhoeae: an accurate alternative to agar dilution in high-MIC strains?

Authors:  Michaël Desjardins; Brigitte Lefebvre; Christian Lavallée; Annie-Claude Labbé; Florian Mauffrey; Irene Martin; Jean Longtin; Claude Fortin
Journal:  Access Microbiol       Date:  2020-03-25

4.  Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.

Authors:  John R Papp; Marie-Claire Rowlinson; Norman P O'Connor; Jason Wholehan; Jafar H Razeq; Anita Glennen; Dapne Ware; Peter C Iwen; Lillian V Lee; Celia Hagan
Journal:  J Med Microbiol       Date:  2017-12-08       Impact factor: 2.472

5.  A Novel Platform Using RNA Signatures To Accelerate Antimicrobial Susceptibility Testing in Neisseria gonorrhoeae.

Authors:  Marjan M Hashemi; Nikhil Ram-Mohan; Xi Yang; Nadya Andini; Nicholas R Gessner; Karen C Carroll; Tza-Huei Wang; Samuel Yang
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

6.  Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.

Authors:  Alan R Katz; Alan Y Komeya; Robert D Kirkcaldy; A Christian Whelen; Olusegun O Soge; John R Papp; Ellen N Kersh; Glenn M Wasserman; Norman P O'Connor; Pamela S O'Brien; Douglas T Sato; Eloisa V Maningas; Gail Y Kunimoto; Juval E Tomas
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

7.  Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.

Authors:  Severin Gose; Duylinh Nguyen; Daniella Lowenberg; Michael Samuel; Heidi Bauer; Mark Pandori
Journal:  BMC Infect Dis       Date:  2013-12-04       Impact factor: 3.090

8.  A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Authors:  Sunniva Foerster; Valentino Desilvestro; Lucy J Hathaway; Christian L Althaus; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.